US 12280063
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease
granted A61KA61K31/13A61K31/27
Quick answer
US patent 12280063 (Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/13, A61K31/27, A61K31/445, A61K31/496